Epstein-Barr Virus Viral Capsid Antigen (VCA) Antibody (IgG)
Test Code
8474
86665
Clinical Significance
Epstein-Barr Virus Viral Capsid Antigen (VCA) Antibody (IgG) - Primary infection by EBV causes infectious mononucleosis, usually a self-limiting disease in children and young adults. Infection with EBV can cause lymphoproliferative disorders including tumors. VCA-IgG is typically detectable at clinical presentation, and persists for life. Absence of VCA-IgG usually indicates the patient is susceptible to EBV infection.
Test Resources
None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Methodology
Immunoassay (IA)
Reference Range(s)
| U/mL | Interpretation |
| <18.00 | Negative |
| 18.00-21.99 | Equivocal |
| >21.99 | Positive |
Alternative Name(s)
VCA EBV IgG,EBV VCA IgG,EBV Capsid Antibody IgG,Viral Capsid Antigen EBV IgG
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 4 days
- Refrigerated: 7 days
- Frozen: 30 days
Setup Schedule
1 mL serum
0.5 mL
Transport tube
Room temperature
Room temperature: 4 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days